344 related articles for article (PubMed ID: 33323018)
1. Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways.
Liu A; Zhang B; Zhao W; Tu Y; Wang Q; Li J
Bioengineered; 2021 Dec; 12(1):183-195. PubMed ID: 33323018
[TBL] [Abstract][Full Text] [Related]
2. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468
[TBL] [Abstract][Full Text] [Related]
3. Tryptanthrin ameliorates imiquimod-induced psoriasis in mice by suppressing inflammation and oxidative stress via NF-κB/MAPK/Nrf2 pathways.
Xiong Y; Wang J; Wang S; Li H; Zhou X
J Nat Med; 2023 Jan; 77(1):188-201. PubMed ID: 36378401
[TBL] [Abstract][Full Text] [Related]
4. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway.
Bai D; Cheng X; Li Q; Zhang B; Zhang Y; Lu F; Sun T; Hao J
Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):133-139. PubMed ID: 36305632
[TBL] [Abstract][Full Text] [Related]
5. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
6. The protective effect and mechanism of catalpol on high glucose-induced podocyte injury.
Chen Y; Liu Q; Shan Z; Zhao Y; Li M; Wang B; Zheng X; Feng W
BMC Complement Altern Med; 2019 Sep; 19(1):244. PubMed ID: 31488111
[TBL] [Abstract][Full Text] [Related]
7. Catalpol Inhibits Homocysteine-induced Oxidation and Inflammation via Inhibiting Nox4/NF-κB and GRP78/PERK Pathways in Human Aorta Endothelial Cells.
Hu H; Wang C; Jin Y; Meng Q; Liu Q; Liu Z; Liu K; Liu X; Sun H
Inflammation; 2019 Feb; 42(1):64-80. PubMed ID: 30315526
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells.
Xiong H; Xu Y; Tan G; Han Y; Tang Z; Xu W; Zeng F; Guo Q
Cell Physiol Biochem; 2015; 35(4):1335-46. PubMed ID: 25720416
[TBL] [Abstract][Full Text] [Related]
9. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of punicalagin attenuates imiquimod-induced psoriasis by reducing ROS generation and inflammation via MAPK/ERK and NF-κB signaling pathways.
Wang Y; Han D; Huang Y; Dai Y; Wang Y; Liu M; Wang N; Yin T; Du W; He K; Zheng Y
Phytother Res; 2024 Feb; 38(2):713-726. PubMed ID: 38009260
[TBL] [Abstract][Full Text] [Related]
11. Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways.
Guo H; Li M; Liu H
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216231
[TBL] [Abstract][Full Text] [Related]
12. Sinomenine Suppressed Keratinocyte Proliferation and Imiquimod-Induced Psoriasis-Like Dermatitis by Regulating lncRNA XIST.
Xiang S; Wu X; Xiang Y
Skin Pharmacol Physiol; 2022; 35(6):328-342. PubMed ID: 35960313
[TBL] [Abstract][Full Text] [Related]
13. Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway.
Li X; Xie X; Zhang L; Meng Y; Li N; Wang M; Zhai C; Liu Z; Di T; Zhang L; Li P
Life Sci; 2019 Feb; 219():311-321. PubMed ID: 30658103
[TBL] [Abstract][Full Text] [Related]
14. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways.
Sangaraju R; Alavala S; Nalban N; Jerald MK; Sistla R
Int Immunopharmacol; 2021 Jul; 96():107754. PubMed ID: 34162135
[TBL] [Abstract][Full Text] [Related]
15. LARP7 alleviates psoriasis symptoms in mice by regulating the SIRT1/NF-κB signaling pathway.
Li N; Liu Y
Allergol Immunopathol (Madr); 2023; 51(1):140-145. PubMed ID: 36617833
[TBL] [Abstract][Full Text] [Related]
16. Catalpol ameliorates LPS-induced endometritis by inhibiting inflammation and TLR4/NF-κB signaling.
Zhang H; Wu ZM; Yang YP; Shaukat A; Yang J; Guo YF; Zhang T; Zhu XY; Qiu JX; Deng GZ; Shi DM
J Zhejiang Univ Sci B; 2019 Oct.; 20(10):816-827. PubMed ID: 31489801
[TBL] [Abstract][Full Text] [Related]
17. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway.
Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S
Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970
[TBL] [Abstract][Full Text] [Related]
18. Catalpol ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by suppressing the JNK and NF-κB pathways.
Zhou J; Xu G; Ma S; Li F; Yuan M; Xu H; Huang K
Biochem Biophys Res Commun; 2015 Nov; 467(4):853-8. PubMed ID: 26474703
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice.
Fu K; Piao T; Wang M; Zhang J; Jiang J; Wang X; Liu H
Int Immunopharmacol; 2014 Dec; 23(2):400-6. PubMed ID: 25063711
[TBL] [Abstract][Full Text] [Related]
20. Orientin alleviates the inflammatory response in psoriasis like dermatitis in BALB/c mice by inhibiting the MAPK signaling pathway.
Long Q; Ma T; Wang Y; Chen S; Tang S; Wang T; Zhou Y; Xu K; Wan P; Cao Y
Int Immunopharmacol; 2024 Jun; 134():112261. PubMed ID: 38761783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
